Skip to Main Content

Paper Details

Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists.
Mol Cancer Ther
0
2022
BAX, BCL-XL, BID, FADD, FLIP(L), IAP, MCL-1, MEDI3039, R2, TP53, TP53 wild-type models, TRAIL, TRAIL-R2, TRAIL-R2, caspase, caspase-8, colorectal, colorectal cell lines, p53, patient, solid, solid tumor, solid tumor cell lines, solid tumors
Author NameAffiliation
Kimberly A McAllisterQueen's University
Kimberly A McAllisterQueen's University
Magali MichautThe Netherlands Cancer Institute
Lodewyk F A WesselsThe Netherlands Cancer Institute
Lodewyk F A Wessels
Ultan McDermottWellcome Sanger Institute
  • 1 - 6

Datasets

Release 1.2